openPR Logo
Press release

Analysis and Opportunity Assessment in Migraine Drugs Market till 2026 by Top Key Players: Pfizer Inc., Aeriel BioPharma, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma Inc., IntelGenx Corp., Luitpold Pharmaceuticals

Analysis and Opportunity Assessment in Migraine Drugs Market

Migraine is a type of neurological disorder which causes headache characterized by vomiting, extreme sensitivity to light, sound, and nausea. The types of migraine are without aura and with aura by the mean of common migraines as well as classical migraines. Usually, Women are more susceptible to suffer severe migraine than men. It is necessary to get a treatment for migraine by taking proper diagnosis and preventive medicines to avoid migraine attack. In terms of treating migraine, market players are investing constantly in research and development to get desired drugs and cure for the disease, further enhancing the global portfolio. With the continuous efforts and high R&D expenses, key players have got numerous successful drugs such as naproxen, sumatriptan, ibuprofen, zolmitriptan, and aspirin to treat or lower the ache or cure the migraine attack.

Request Sample for more Professional and Technical insights @
http://bit.ly/2Dootun

Migraine is most common between the ages of 25 and 55 and this ailment is tending to run in family by mean that, approximately 90% cases of migraine cases do have family history for the disease. According to the Migraine Research Foundation, Migraine is the third most widespread neurological disease, affecting 39 million children, women, and men in the U.S. and 1 billion globally. Thus, growing number of people having migraine and high probabilities of occurrence of this illness along with its hereditary phenomena is anticipated to boost the Migraine Drugs Market in the forecast period. In addition, improved awareness for the migraine drugs and treatments, coupled with technological advancement for the manufacturing of anti-migraine drugs are other factors anticipated to propel the market growth.

Increasing occurrences of migraine attack is anticipated to bolster growth for migraine drugs Migraine Drugs Market.

North America region observed to dominate the market due to rising incidences of migraine attacks and the high demand for drugs.

Key players of Migraine Drugs Market:
• Pfizer Inc.
• Aeriel BioPharma
• Alder BioPharmaceuticals Inc.
• Amgen Inc., Astellas Pharma Inc.
• IntelGenx Corp.
• Luitpold Pharmaceuticals
• Teva Pharmaceutical Industries LTD
• AstraZeneca plc
• GlaxoSmithKline plc
• Endo International plc
• CoLucid Pharmaceuticals Inc.
• Johnson & Johnson
• Valeant Pharmaceuticals International, Inc.
• Zogenix Inc.
• Abbott Laboratories
• Aegis Therapeutics, LLC.
• WINSTON PHARMACEUTICALS, Inc.
• Kowa Pharmaceuticals America
• Reddy’s Laboratories Ltd.

For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2DmFl4y

Migraine Drugs Market is segmented on the basis of drug type, route of administration, distribution channel, and geography.

On the basis of Migraine drug type, the market is segmented into:
• Triptans
• Sumatriptan
• Zolmitriptan
• Rizatriptan
• Frovatriptan
• Others
• Ergot Alkaloids

On the basis of route of administration, the Migraine Drugs Market is segmented into:
• Oral
• Injectable

On the basis of distribution channel, the Migraine Drugs Market is segmented into:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

On the basis of geography, North America region is estimated to dominate the Migraine Drugs Market. The high market growth in this region is attributed to factors such as increased healthcare expenditure and convenience of getting specialty migraine drugs. In addition, rising incidence of migraine attacks in U.S. and Canada is anticipated to boost the market growth in this region. According to Migraine Research Foundation, approximately 1 in 4 U.S. families includes a person with migraine disease. Moreover, at every 10 seconds, a person in the U.S. has to visit the emergency room complaining of head ache, and around 1.2 million hospital visits are due to acute migraine attacks. Thus, high incidence rate and growing demand for the drugs to treat or cure the migraine is further anticipated to bolster the market growth in North America.

Browse Full Report with Complete TOC @
https://www.polarismarketresearch.com/industry-analysis/migraine-drugs-market/

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analysis and Opportunity Assessment in Migraine Drugs Market till 2026 by Top Key Players: Pfizer Inc., Aeriel BioPharma, Alder BioPharmaceuticals Inc., Amgen Inc., Astellas Pharma Inc., IntelGenx Corp., Luitpold Pharmaceuticals here

News-ID: 1373978 • Views: 338

More Releases from Polaris Market Research & Consulting

Access Control System Market 2027 | 3M Cogent Inc., Accu-Time Systems Inc., Awar …
Polaris Market Research has announced the addition of the " Access Control System Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Access Control System Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/access-control-system-market/request-for-sample The key players covered in this study • Honeywell International • Bosch security • Johnson Controls • Accu-Time Systems Inc. • Bio-Key International Inc. • United
Special Effect Masterbatches Market Size Worth $4.69 Billion By 2027 | Industry …
Polaris Market Research has announced the addition of the " Special Effect Masterbatches Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Special Effect Masterbatches Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report provides in depth study of "Special Effect Masterbatches Market" using SWOT analysis i.e. Strength, Weakness,
Marine Seats Market Global Study Report 2027 | Grammer AG, Leader Accessories LL …
Polaris Market Research has announced the addition of the " Marine Seats Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Marine Seats Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report provides in depth study of "Marine Seats Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat
Asphalt Pavers Market Overall Global Study Report 2027 | Caterpillar, Sunroc Cor …
Polaris Market Research has announced the addition of the " Asphalt Pavers Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Asphalt Pavers Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report provides in depth study of "Asphalt Pavers Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat

All 5 Releases


More Releases for Migraine

Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
EpiCast Report: Migraine-Epidemiology Forecast to 2026
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Migraine Market: Industry Analysis & Outlook 2021
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine